Skip to main content
Top
Published in: International Urology and Nephrology 5/2024

13-11-2023 | Chronic Kidney Disease | Nephrology - Original Paper

The associations of weekend warrior and other physical activity patterns with the risk of all-cause and cardiovascular disease mortality in people with diabetes mellitus and chronic kidney disease: from NHANES 2007–2020

Authors: Qing Yang, Wenjie Yang, Fang Liu

Published in: International Urology and Nephrology | Issue 5/2024

Login to get access

Abstract

Aim

To investigate the associations of the weekend warrior and other physical activity (PA) patterns with all-cause, cardiovascular disease (CVD) mortality risk in people with diabetes mellitus (DM) and chronic kidney disease (CKD).

Methods

This study pooled the data from NHANES 2007–2020. Participants with DM and CKD were included. PA was assessed using a self-reported questionnaire. According to the characteristics of recreational activities, individuals were categorized as inactive (no activities), insufficiently active (total PA duration <  150 min/week), weekend warrior (total PA duration ≥  150 min/week for 1–2 sessions), and regularly active (total PA duration ≥  150 min/week for ≥  3 sessions). Weighted Cox regression models with adjusting sociodemographic, behavioral, and metabolic factors were performed to investigate the relationship of PA patterns with all-cause and CVD mortality risk. Stratification and interaction analyses were further performed.

Results

Among 1702 participants (46.53% female; 64 ± 0.46 years old), 536 died (163 cardiovascular) during the follow-up of 68 (39–104) months. The hazard ratio (HR) of all-cause death was 0.618 (95% CI 0.406–0.942) for insufficiently active PA pattern, 0.338 (95% CI 0.116–0.988) for weekend warrior PA pattern, and 0.536 (95% CI 0.395–0.726) for regularly active PA pattern compared with inactive PA pattern. HR of CVD death was 0.545 (95% CI 0.250–1.189) for the PA pattern of insufficiently active, 0.165 (95% CI 0.020–1.343) for weekend warrior, and 0.393 (95% CI 0.218–0.710) for regularly active compared with the inactive PA pattern. The associations present no difference in subgroups. Moreover, there was no discernible difference between weekend warrior and regularly active PA patterns for all-cause and CVD deaths. The risk of death declined relatively quickly When exercise was initiated and to a total of 450 min or 4 times per week.

Conclusion

In a population of DM and CKD, the weekend warrior pattern was similar to regular activity to lower the risk of all-cause mortality, compared with inactivity. The weekend warrior pattern was recommended for people who only have time to exercise on the weekend. However, longer and larger sample cohort studies are needed to validate our findings.
Appendix
Available only for authorised users
Literature
1.
go back to reference International Diabetes Federation (2021) IDF diabetes atlas, 10th edn. International Diabetes Federation, Brussels, Belgium International Diabetes Federation (2021) IDF diabetes atlas, 10th edn. International Diabetes Federation, Brussels, Belgium
Metadata
Title
The associations of weekend warrior and other physical activity patterns with the risk of all-cause and cardiovascular disease mortality in people with diabetes mellitus and chronic kidney disease: from NHANES 2007–2020
Authors
Qing Yang
Wenjie Yang
Fang Liu
Publication date
13-11-2023
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 5/2024
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-023-03863-z

Other articles of this Issue 5/2024

International Urology and Nephrology 5/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine